Abstract
The presented tumors in this chapter are somewhat very rare, and their management is still debated due to the scarcity of information about their cell of origin, behavior, and biology. Treatment options are still limited, but we are confident that in the near future by discovering the genetic and biological mechanisms that drive tumor growth we will be able to offer new target therapies that should be flanked by surgery, radiotherapy, and chemotherapeutic agents actually in use. The purpose of this chapter is to highlight the most important known characteristics of these tumors offering the chance to recognize the disease and then offer the best opportunity for treatment to patients. The 5th WHO Classification Central Nervous System features substantial changes by moving further to advance the role of molecular diagnostics in CNS tumor classification, but remaining rooted in other established approaches to tumor characterization, including histology and immunohistochemistry, and probably, the category of many tumors will change. Here, the most important characteristics of each neoplasm are summarized focusing on genetic mechanisms and molecular pathways, their histopathologic footprints, signs and symptoms, radiologic features, therapeutic approaches, and prognosis as well as follow-up protocols. Schematic classifications are also presented to offer a better understanding of the pathology.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdulkader MM, Mansour NH, Van Gompel JJ, Bosh GA, Dropcho EJ, Bonnin JM, Cohen-Gadol AA (2016) Disseminated choroid plexus papillomas in adults: a case series and review of the literature. J Clin Neurosci 32:148–154. https://doi.org/10.1016/j.jocn.2016.04.002
Abel TW et al (2005) Lhermitte-Duclos disease: a report of 31 cases with immunohistochemical analysis of the PTEN/AKT/mTOR pathway. J Neuropathol Exp Neurol 64:341–349. https://doi.org/10.1093/jnen/64.4.341
Adachi J, Nishikawa R, Hirose T, Matsutani M (2005) Mixed neuronal-glial tumor of the fourth ventricle and successful treatment of postoperative mutism with bromocriptine: case report. Surg Neurol 63:375–379. https://doi.org/10.1016/j.surneu.2004.05.039
Ayala-Ramirez M et al (2011) Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. J Clin Endocrinol Metab 96:717–725. https://doi.org/10.1210/jc.2010-1946
Badalian-Very G et al (2010) Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood 116:1919–1923. https://doi.org/10.1182/blood-2010-04-279083
Baek WK, Lachkar S, Iwanaga J, Oskouian RJ, Loukas M, Oakes WJ, Tubbs RS (2018) Comprehensive review of spinal neurenteric cysts with a focus on histopathological findings. Cureus 10:e3379. https://doi.org/10.7759/cureus.3379
Bianchi F, Tamburrini G, Massimi L, Caldarelli M (2016) Supratentorial tumors typical of the infantile age: desmoplastic infantile ganglioglioma (DIG) and astrocytoma (DIA). A Review Childs Nerv Syst 32:1833–1838. https://doi.org/10.1007/s00381-016-3149-4
Bidinotto LT et al (2015) Molecular profiling of a rare rosette-forming glioneuronal tumor arising in the spinal cord. PLoS ONE 10:e0137690. https://doi.org/10.1371/journal.pone.0137690
Blumcke I, Wiestler OD (2002) Gangliogliomas: an intriguing tumor entity associated with focal epilepsies. J Neuropathol Exp Neurol 61:575–584. https://doi.org/10.1093/jnen/61.7.575
Braoudaki M, Lambrou GI, Papadodima SA, Stefanaki K, Prodromou N, Kanavakis E (2016) MicroRNA expression profiles in pediatric dysembryoplastic neuroepithelial tumors. Med Oncol 33:5. https://doi.org/10.1007/s12032-015-0719-3
Browne JD, Fisch U, Valavanis A (1993) Surgical therapy of glomus vagale tumors. Skull Base Surg 3:182–192. https://doi.org/10.1055/s-2008-1060583
Buffet A et al (2012) A decade (2001–2010) of genetic testing for pheochromocytoma and paraganglioma. Horm Metab Res 44:359–366. https://doi.org/10.1055/s-0032-1304594
Burnichon N et al (2012) MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma. Clin Cancer Res 18:2828–2837. https://doi.org/10.1158/1078-0432.Ccr-12-0160
Carneiro SS, Scheithauer BW, Nascimento AG, Hirose T, Davis DH (1996) Solitary fibrous tumor of the meninges: a lesion distinct from fibrous meningioma. A clinicopathologic and immunohistochemical study. Am J Clin Pathol 106:217–224. https://doi.org/10.1093/ajcp/106.2.217
Cascon A et al (2015) Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene. J Natl Cancer Inst 107. https://doi.org/10.1093/jnci/djv053
Cerisano V et al (2004) Molecular mechanisms of CD99-induced caspase-independent cell death and cell-cell adhesion in Ewing’s sarcoma cells: actin and zyxin as key intracellular mediators. Oncogene 23:5664–5674. https://doi.org/10.1038/sj.onc.1207741
Chakraborty R et al. (2014) Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis Blood 124:3007–3015. https://doi.org/10.1182/blood-2014-05-577825
Chappe C et al (2013) Dysembryoplastic neuroepithelial tumors share with pleomorphic xanthoastrocytomas and gangliogliomas BRAF(V600E) mutation and expression. Brain Pathol 23:574–583. https://doi.org/10.1111/bpa.12048
Chen YW, Wong TT, Ho DM, Huang PI, Chang KP, Shiau CY, Yen SH (2006) Impact of radiotherapy for pediatric CNS atypical teratoid/rhabdoid tumor (single institute experience). Int J Radiat Oncol Biol Phys 64:1038–1043. https://doi.org/10.1016/j.ijrobp.2005.10.001
Chmielecki J et al (2013) Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat Genet 45:131–132. https://doi.org/10.1038/ng.2522
Courtillot C et al (2016) Endocrine manifestations in a monocentric cohort of 64 patients with erdheim-chester disease. J Clin Endocrinol Metab 101:305–313. https://doi.org/10.1210/jc.2015-3357
Czapiewski P et al (2018) Frequent expression of somatostatin receptor 2a in olfactory neuroblastomas: a new and distinctive feature. Hum Pathol 79:144–150. https://doi.org/10.1016/j.humpath.2018.05.013
Dang L, Fan X, Chaudhry A, Wang M, Gaiano N, Eberhart CG (2006) Notch3 signaling initiates choroid plexus tumor formation. Oncogene 25:487–491. https://doi.org/10.1038/sj.onc.1209074
Davies H et al (2002) Mutations of the BRAF gene in human cancer. Nature 417:949–954. https://doi.org/10.1038/nature00766
Duffner PK et al. (1994) Desmoplastic infantile gangliogliomas: an approach to therapy. Neurosurgery 34:583–589; discussion 589. https://doi.org/10.1227/00006123-199404000-00003
Ellezam B, Theeler BJ, Luthra R, Adesina AM, Aldape KD, Gilbert MR (2012) Recurrent PIK3CA mutations in rosette-forming glioneuronal tumor. Acta Neuropathol 123:285–287. https://doi.org/10.1007/s00401-011-0886-z
Emile JF et al (2021) Histiocytosis Lancet 398:157–170. https://doi.org/10.1016/S0140-6736(21)00311-1
Eye PG, Davidson L, Malafronte PJ, Cantrell S, Theeler BJ (2017) PIK3CA mutation in a mixed dysembryoplastic neuroepithelial tumor and rosette forming glioneuronal tumor, a case report and literature review. J Neurol Sci 373:280–284. https://doi.org/10.1016/j.jns.2016.11.003
Faragalla H, Weinreb I (2009) Olfactory neuroblastoma: a review and update. Adv Anat Pathol 16:322–331. https://doi.org/10.1097/PAP.0b013e3181b544cf
Fiani B et al (2019) Esthesioneuroblastoma: a comprehensive review of diagnosis management, and current treatment options. World Neurosurg 126:194–211. https://doi.org/10.1016/j.wneu.2019.03.014
Fisch U (1982) Infratemporal fossa approach for glomus tumors of the temporal bone. Ann Otol Rhinol Laryngol 91:474–479. https://doi.org/10.1177/000348948209100502
Gandhoke CS et al (2017) A rare case report of mixed olfactory neuroblastoma: carcinoma with review of literature. Surg Neurol Int 8:83. https://doi.org/10.4103/sni.sni_30_17
Gessi M, Lambert SR, Lauriola L, Waha A, Collins VP, Pietsch T (2012) Absence of KIAA1549-BRAF fusion in rosette-forming glioneuronal tumors of the fourth ventricle (RGNT). J Neurooncol 110:21–25. https://doi.org/10.1007/s11060-012-0940-2
Gimenez-Roqueplo AP et al (2003) Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Res 63:5615–5621
Greer A, Foreman NK, Donson A, Davies KD, Kleinschmidt-DeMasters BK (2017) Desmoplastic infantile astrocytoma/ganglioglioma with rare BRAF V600D mutation. Pediatr Blood Cancer 64. https://doi.org/10.1002/pbc.26350
Haas RL et al (2020) Extrameningeal solitary fibrous tumors-surgery alone or surgery plus perioperative radiotherapy: a retrospective study from the global solitary fibrous tumor initiative in collaboration with the sarcoma patients EuroNet. Cancer 126:3002–3012. https://doi.org/10.1002/cncr.32911
Hassoun J, Gambarelli D, Grisoli F, Pellet W, Salamon G, Pellissier JF, Toga M (1982) Central neurocytoma. An electron-microscopic study of two cases acta. Neuropathol 56:151–156. https://doi.org/10.1007/BF00690587
Hingwala DR, Radhakrishnan N, Kesavadas C, Thomas B, Kapilamoorthy TR, Radhakrishnan VV (2013) Neuroenteric cysts of the brain-comprehensive magnetic resonance imaging. Indian J Radiol Imaging 23:155–163. https://doi.org/10.4103/0971-3026.116579
Histiocytosis syndromes in children (1987) Writing Group of the Histiocyte Society. Lancet 1:208–209
Hornick JL, Fletcher CD (2005) Soft tissue perineurioma: clinicopathologic analysis of 81 cases including those with atypical histologic features. Am J Surg Pathol 29:845–858
Hsu C, Kwan G, Lau Q, Bhuta S (2012) Rosette-forming glioneuronal tumour: imaging features, histopathological correlation and a comprehensive review of literature. Br J Neurosurg 26:668–673. https://doi.org/10.3109/02688697.2012.655808
Hummel TR, Miles L, Mangano FT, Jones BV, Geller JI (2012) Clinical heterogeneity of desmoplastic infantile ganglioglioma: a case series and literature review. J Pediatr Hematol Oncol 34:e232-236. https://doi.org/10.1097/MPH.0b013e3182580330
Jackson CG, Glasscock ME 3rd, Harris PF (1982) Glomus tumors diagnosis, classification, and management of large lesions. Arch Otolaryngol 108:401–410. https://doi.org/10.1001/archotol.1982.00790550005002
Joseph JJ, Das JM (2021) Choroid plexus papilloma. In: StatPearls. StatPearls Publishing Copyright © 2021, StatPearls Publishing LLC., Treasure Island (FL)
Kadish S, Goodman M, Wang CC (1976) Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer 37:1571–1576. https://doi.org/10.1002/1097-0142(197603)37:3<1571::aid-cncr2820370347>3.0.co;2-l
Kane AJ, Sughrue ME, Rutkowski MJ, Tihan T, Parsa AT (2011) The molecular pathology of central neurocytomas. J Clin Neurosci 18:1–6. https://doi.org/10.1016/j.jocn.2010.06.004
King KS et al (2011) Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations. J Clin Oncol 29:4137–4142. https://doi.org/10.1200/jco.2011.34.6353
Kitange G et al (2005) Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas. Genes Chromosomes Cancer 42:68–77. https://doi.org/10.1002/gcc.20108
Kovar H, Dworzak M, Strehl S, Schnell E, Ambros IM, Ambros PF, Gadner H (1990) Overexpression of the pseudoautosomal gene MIC2 in Ewing’s sarcoma and peripheral primitive neuroectodermal tumor. Oncogene 5:1067–1070
Kristensen BW, Priesterbach-Ackley LP, Petersen JK, Wesseling P (2019) Molecular pathology of tumors of the central nervous system. Ann Oncol 30:1265–1278. https://doi.org/10.1093/annonc/mdz164
Lang FF, Epstein FJ, Ransohoff J, Allen JC, Wisoff J, Abbott IR, Miller DC (1993) Central nervous system gangliogliomas. Part 2: Clinical outcome. J Neurosurg 79:867–873. https://doi.org/10.3171/jns.1993.79.6.0867
Lee J, Kim DS, Han JW, Suh CO (2017) Atypical teratoid/rhabdoid tumors in children treated with multimodal therapies: the necessity of upfront radiotherapy after surgery. Pediatr Blood Cancer 64. https://doi.org/10.1002/pbc.26663
Liao JM, Wang W, Xie J, Wu HB (2018) Dysembryoplastic neuroepithelial tumor-like pilocytic astrocytoma: a case report. Medicine (Baltimore) 97:e10755. https://doi.org/10.1097/MD.0000000000010755
Lin FY et al (2016) Integrated tumor and germline whole-exome sequencing identifies mutations in MAPK and PI3K pathway genes in an adolescent with rosette-forming glioneuronal tumor of the fourth ventricle Cold Spring Harb. Mol Case Stud 2:a001057. https://doi.org/10.1101/mcs.a001057
Louis DN et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109. https://doi.org/10.1007/s00401-007-0243-4
Louis DN et al (2016) The 2016 World health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820. https://doi.org/10.1007/s00401-016-1545-1
Louis DN et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro-Oncology 23:1231–1251. https://doi.org/10.1093/neuonc/noab106
Luyken C, Blumcke I, Fimmers R, Urbach H, Wiestler OD, Schramm J (2004) Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years. Cancer 101:146–155. https://doi.org/10.1002/cncr.20332
Mannelli M et al (2009) Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas. J Clin Endocrinol Metab 94:1541–1547. https://doi.org/10.1210/jc.2008-2419
Martin-Broto J et al (2020) Assessment of safety and efficacy of combined trabectedin and low-dose radiotherapy for patients with metastatic soft-tissue sarcomas: a nonrandomized phase 1/2 clinical trial. JAMA Oncol 6:535–541. https://doi.org/10.1001/jamaoncol.2019.6584
Martin-Broto J, Mondaza-Hernandez JL, Moura DS, Hindi N (2021) A comprehensive review on solitary fibrous tumor: New Insights for New Horizons Cancers (Basel) 13. https://doi.org/10.3390/cancers13122913
Mehta VS, Chowdhury C, Bhatia R (1984) Neuroenteric cyst of the cerebellum. Postgrad Med J 60:287–289. https://doi.org/10.1136/pgmj.60.702.287
Miller DC, Lang FF, Epstein FJ (1993) Central nervous system gangliogliomas. Part 1: Pathology J Neurosurg 79:859–866. https://doi.org/10.3171/jns.1993.79.6.0859
Moazzam AA, Wagle N, Shiroishi MS (2014) Malignant transformation of DNETs: a case report and literature review. NeuroReport 25:894–899. https://doi.org/10.1097/WNR.0000000000000184
Nelson DS et al (2015) MAP2K1 and MAP3K1 mutations in langerhans cell histiocytosis. Genes Chromosomes Cancer 54:361–368. https://doi.org/10.1002/gcc.22247
Neumann HP et al (1993) Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. N Engl J Med 329:1531–1538. https://doi.org/10.1056/NEJM199311183292103
Neumann HPH, Young WF, Eng C (2019) Pheochromocytoma and paraganglioma. N Engl J Med 381:552–565. https://doi.org/10.1056/NEJMra1806651
Nowak DA, Trost HA (2002) Lhermitte-Duclos disease (dysplastic cerebellar gangliocytoma): a malformation, hamartoma or neoplasm? Acta Neurol Scand 105:137–145. https://doi.org/10.1034/j.1600-0404.2002.1r127.x
Nunes Dias L, Puerta Roldan P, Guillen Quesada A, Sunol Capella M, Hinojosa J (2019) Supratentorial neuroenteric cyst in children: a case report and brief literature review. Childs Nerv Syst 35:2227–2231. https://doi.org/10.1007/s00381-019-04190-4
Ohgaki H, Kleihues P (2005) Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas J Neuropathol Exp Neurol 64:479–489 doi:https://doi.org/10.1093/jnen/64.6.479
Okamoto H, Mineta T, Ueda S, Nakahara Y, Shiraishi T, Tamiya T, Tabuchi K (2005) Detection of JC virus DNA sequences in brain tumors in pediatric patients. J Neurosurg 102:294–298. https://doi.org/10.3171/ped.2005.102.3.0294
Ostrom QT et al (2014) The descriptive epidemiology of atypical teratoid/rhabdoid tumors in the United States, 2001–2010. Neuro Oncol 16:1392–1399. https://doi.org/10.1093/neuonc/nou090
Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS (2020) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013–2017. Neuro Oncol 22:iv1–iv96. https://doi.org/10.1093/neuonc/noaa200
Pai Panandiker AS et al (2012) Sequencing of local therapy affects the pattern of treatment failure and survival in children with atypical teratoid rhabdoid tumors of the central nervous system. Int J Radiat Oncol Biol Phys 82:1756–1763. https://doi.org/10.1016/j.ijrobp.2011.02.059
Papathomas TG et al (2015) SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a multinational study of the European network for the study of adrenal tumors (ENS@T). Mod Pathol 28:807–821. https://doi.org/10.1038/modpathol.2015.41
Pawel BR (2018) SMARCB1-deficient tumors of childhood: a practical guide. Pediatr Dev Pathol 21:6–28. https://doi.org/10.1177/1093526617749671
Pereira BD, Luiz HV, Ferreira AG, Portugal J (2019) Genetics of pheochromocytoma and paraganglioma. In: Mariani-Costantini R (ed) Paraganglioma: a multidisciplinary approach. Brisbane (AU). https://doi.org/10.15586/paraganglioma.2019.ch1
Prabowo AS et al (2015) Landscape of chromosomal copy number aberrations in gangliogliomas and dysembryoplastic neuroepithelial tumours. Neuropathol Appl Neurobiol 41:743–755. https://doi.org/10.1111/nan.12235
Qaddoumi I et al (2016) Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology. Acta Neuropathol 131:833–845. https://doi.org/10.1007/s00401-016-1539-z
Ray WZ et al (2009) Clinicopathologic features of recurrent dysembryoplastic neuroepithelial tumor and rare malignant transformation: a report of 5 cases and review of the literature. J Neurooncol 94:283–292. https://doi.org/10.1007/s11060-009-9849-9
Rivera B et al (2016) Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors. Acta Neuropathol 131:847–863. https://doi.org/10.1007/s00401-016-1549-x
Safaee M et al (2013) The relative patient benefit of gross total resection in adult choroid plexus papillomas. J Clin Neurosci 20:808–812. https://doi.org/10.1016/j.jocn.2012.08.003
Sagna Y et al (2019) Endocrine manifestations in a cohort of 63 adulthood and childhood onset patients with Langerhans cell histiocytosis. Eur J Endocrinol 181:275–285. https://doi.org/10.1530/EJE-19-0177
Salas S et al (2017) Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database. Ann Oncol 28:1979–1987. https://doi.org/10.1093/annonc/mdx250
Schenkel AR, Dufour EM, Chew TW, Sorg E, Muller WA (2007) The murine CD99-related molecule CD99-like 2 (CD99L2) is an adhesion molecule involved in the inflammatory response. Cell Commun Adhes 14:227–237. https://doi.org/10.1080/15419060701755966
Schild SE, Scheithauer BW, Haddock MG, Schiff D, Burger PC, Wong WW, Lyons MK (1997) Central neurocytomas. Cancer 79:790–795. https://doi.org/10.1002/(sici)1097-0142(19970215)79:4%3c790::aid-cncr16%3e3.0.co;2-v
Schindler G et al (2011) Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 121:397–405. https://doi.org/10.1007/s00401-011-0802-6
Schmidt MH, Gottfried ON, von Koch CS, Chang SM, McDermott MW (2004) Central neurocytoma: a review. J Neurooncol 66:377–384. https://doi.org/10.1023/b:neon.0000014541.87329.3b
Shamblin WR, ReMine WH, Sheps SG, Harrison EG Jr (1971) Carotid body tumor (chemodectoma). Clinicopathologic analysis of ninety cases. Am J Surg 122:732–739. https://doi.org/10.1016/0002-9610(71)90436-3
Sharma P, Swain M, Padua MD, Ranjan A, Lath R (2011) Rosette-forming glioneuronal tumors: a report of two cases. Neurol India 59:276–280. https://doi.org/10.4103/0028-3886.79148
Sievers P et al (2019) Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1. Acta Neuropathol 138:497–504. https://doi.org/10.1007/s00401-019-02038-4
Soler ZM, Smith TL (2012) Endoscopic versus open craniofacial resection of esthesioneuroblastoma: what is the evidence? Laryngoscope 122:244–245. https://doi.org/10.1002/lary.22450
Tan CL, Landi D, Fuchs H, McLendon RE (2018) Novel case of recurrent intraventricular atypical central neurocytoma with prominent gangliogliomatous differentiation in a 10-year-old boy with 10 years of follow up. Neuropathology 38:542–548. https://doi.org/10.1111/neup.12502
Taylor HC, Mayes D, Anton AH (1986) Clonidine suppression test for pheochromocytoma: examples of misleading results. J Clin Endocrinol Metab 63:238–242. https://doi.org/10.1210/jcem-63-1-238
Thompson LD (2009) Olfactory Neuroblastoma. Head Neck Pathol 3:252–259. https://doi.org/10.1007/s12105-009-0125-2
Thurston B, Gunny R, Anderson G, Paine S, Thompson D, Jacques T, Ternier J (2013) Fourth ventricle rosette-forming glioneuronal tumour in children: an unusual presentation in an 8-year-old patient, discussion and review of the literature. Childs Nerv Syst 29:839–847. https://doi.org/10.1007/s00381-012-1993-4
Tonetti DA, Ares WJ, Richardson RM, Hamilton RL, Lieberman FS (2017) Long-term recurrence of dysembryoplastic neuroepithelial tumor: clinical case report. Surg Neurol Int 8:140. https://doi.org/10.4103/2152-7806.210257
Tsokos M, Alaggio RD, Dehner LP, Dickman PS (2012) Ewing sarcoma/peripheral primitive neuroectodermal tumor and related tumors. Pediatr Dev Pathol 15:108–126. https://doi.org/10.2350/11-08-1078-PB.1
van Nederveen FH et al (2009) An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB SDHC, or SDHD Gene mutations: a retrospective and prospective analysis. Lancet Oncol 10:764–771. https://doi.org/10.1016/S1470-2045(09)70164-0
Walther MM, Herring J, Enquist E, Keiser HR, Linehan WM (1999) von Recklinghausen’s disease and pheochromocytomas. J Urol 162:1582–1586
Wang Q, Zhang S, Cheng J, Liu W, Hui X (2017) Lhermitte-Duclos disease: clinical study with long-term follow-up in a single institution. Clin Neurol Neurosurg 162:53–58. https://doi.org/10.1016/j.clineuro.2017.09.007
Weis S, Sonnberger M, Dunzinger A, Voglmayr E, Aichholzer M, Kleiser R, Strasser P (2019) Dysembryoplastic neuroepithelial tumor (DNT). In: Imaging brain diseases: a neuroradiology, nuclear medicine, neurosurgery, neuropathology and molecular biology-based approach. Springer Vienna, Vienna, pp 1533–1543. https://doi.org/10.1007/978-3-7091-1544-2_62
Welander J, Söderkvist P, Gimm O (2011) Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Endocr Relat Cancer 18:R253-276. https://doi.org/10.1530/erc-11-0170
Xiong J, Liu Y, Chu SG, Chen H, Chen HX, Mao Y, Wang Y (2012) Rosette-forming glioneuronal tumor of the septum pellucidum with extension to the supratentorial ventricles: rare case with genetic analysis. Neuropathology 32:301–305. https://doi.org/10.1111/j.1440-1789.2011.01261.x
Yamada S et al (2019) An epilepsy-associated glioneuronal tumor with mixed morphology harboring FGFR1 mutation. Pathol Int 69:372–377. https://doi.org/10.1111/pin.12799
Yang C et al (2017) Histopathological, molecular, clinical and radiological characterization of rosette-forming glioneuronal tumor in the central nervous system. Oncotarget 8:109175–109190. https://doi.org/10.18632/oncotarget.22646
Zhen HN et al (1999) Expression of the simian virus 40 large tumor antigen (Tag) and formation of Tag-p53 and Tag-pRb complexes in human brain tumors. Cancer 86:2124–2132
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Capitanio, J.F., Mortini, P. (2023). Other Less Prevalent Tumors of the Central Nervous System. In: Rezaei, N., Hanaei, S. (eds) Human Brain and Spinal Cord Tumors: From Bench to Bedside. Volume 2. Advances in Experimental Medicine and Biology, vol 1405. Springer, Cham. https://doi.org/10.1007/978-3-031-23705-8_24
Download citation
DOI: https://doi.org/10.1007/978-3-031-23705-8_24
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-23704-1
Online ISBN: 978-3-031-23705-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)